Search research articles
Contact Us
Filters
Showing results (641-650 of 703) with videos related to
Page
of 71
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer
Antonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer
E L Mayer, D Trapani, S-E Kim, et al.
Radiology
|
February 24, 2021
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
Anton S Becker, Rocio Perez-Johnston, Sona A Chikarmane, et al.
Resources, Conservation, and Recycling
|
September 14, 2020
A perspective on the role of uncertainty in sustainability science and engineering
U Diwekar, A Amekudzi-Kennedy, B Bakshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
Siang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Cytotherapy
|
October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
Joline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Breast Cancer Research : BCR
|
October 7, 2024
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Nature Structural & Molecular Biology
|
July 10, 2023
Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein
Jun Zhang, Weichun Tang, Hailong Gao, et al.
Page
of 71
Search research articles
Search
Showing results (641-650 of 703) with videos related to
Sort By:
Page
of 71
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer
Antonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer
E L Mayer, D Trapani, S-E Kim, et al.
Radiology
|
February 24, 2021
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
Anton S Becker, Rocio Perez-Johnston, Sona A Chikarmane, et al.
Resources, Conservation, and Recycling
|
September 14, 2020
A perspective on the role of uncertainty in sustainability science and engineering
U Diwekar, A Amekudzi-Kennedy, B Bakshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
Siang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Cytotherapy
|
October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
Joline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Breast Cancer Research : BCR
|
October 7, 2024
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Nature Structural & Molecular Biology
|
July 10, 2023
Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein
Jun Zhang, Weichun Tang, Hailong Gao, et al.
Page
of 71